C-DRUG

C:DRUG - Bright Minds Biosciences Inc. - Common Shares - https://www.brightmindsbio.com

04:20:39 EDT

Sym-X				Last	Vol	$Vol	#Tr	Year Hi-Lo	Last Tr	News	Delay
DRUG - C	·	39.00	0.7	34.96	0.2	7	12	108.00 1.30	11:32:09	May 28	15 min RT 2¢
CSE - C	·	39.00	0.7	34.96	0.2	6	3	108.00 1.30	11:32:09		15 min
CXD - D				34.96	0.07	2	9		Jun 30		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 12

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:36:52	D	33.51	-1.45	52	2 RBC	2 RBC	E
13:17:17	D	34.31	-0.65	2	80 National Bank	80 National Bank	E
13:15:57	D	34.44	-0.52	5	80 National Bank	80 National Bank	E
12:23:08	D	34.18	-0.78	1	80 National Bank	80 National Bank	E
12:10:33	D	34.33	-0.63	2	80 National Bank	80 National Bank	E
11:32:09	C	34.81	-0.15	50	7 TD Sec	36 Latimer	E
10:07:11	D	35.32	0.36	1	80 National Bank	80 National Bank	E
09:45:25	D	34.94	-0.02	1	80 National Bank	80 National Bank	E
09:45:20	C	35.04	0.08	60	7 TD Sec	36 Latimer	E
09:30:00	C	36.70	1.74	50	7 TD Sec	36 Latimer	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2025-05-28 08:00	C:DRUG	39.26	News Release200	Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
2025-05-20 08:00	C:DRUG	45.23	News Release200	Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025
2025-05-15 19:20	C:DRUG	45.23	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-05-15 19:14	C:DRUG	45.23	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-05-13 18:30	C:DRUG	45.71	News Release200	Bright Minds' DBA/2 mouse study shows no drop attacks
2025-04-28 17:59	C:DRUG	45.05	News Release200	Bright Minds to hold virtual R&D day on May 20
2025-03-04 17:25	C:DRUG	46.32	News Release200	Bright Minds Bio adds five epilepsy researchers to SAB
2025-02-24 06:50	C:DRUG	51.16	News Release200	Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
2025-02-13 16:33	C:DRUG	66.76	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-02-13 16:33	C:DRUG	66.76	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-01-07 14:54	C:DRUG	58.31	News Release200	Bright Minds appoints Collins as chief medical officer
2024-12-30 16:18	C:DRUG	53.24	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-12-30 16:18	C:DRUG	53.24	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-12-30 16:18	C:DRUG	53.24	SEDAR MD & A815	SEDAR MD & A
2024-11-21 09:00	C:DRUG	46.99	News Release200	Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
2024-11-04 17:56	C:DRUG	69.41	News Release200	Bright Minds closes $35M (U.S.) financing
2024-10-21 16:39	C:DRUG	67.50	News Release200	Bright Minds, Firefly to analyze phase 2 study data
2024-10-18 09:00	C:DRUG	30.00	News Release200	Bright Minds Biosciences arranges $35M (U.S.) financing
2024-10-16 17:28	C:DRUG	39.29	News Release200	Bright Minds finds BMB-201, morphine have like efficacy
2024-10-16 16:52	C:DRUG	39.29	News Release200	Bright Minds to analyze Firefly compound data

Date ET

Symbol

Price

Type

Headline

2025-05-28 08:00

C:DRUG

39.26

News Release

Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

2025-05-20 08:00

C:DRUG